-
公开(公告)号:US06333326B1
公开(公告)日:2001-12-25
申请号:US09367303
申请日:1999-08-02
IPC分类号: C07D40114
CPC分类号: C07D401/14
摘要: This invention relates to 2,3(1H,4H)-quinoxalinedione derivatives which are selective antagonists of N-methyl-D-aspartate receptors. More particularly, this invention relates to 5-triazolyl-2,3(1H,4H)-quinoxalinedione derivatives and to the preparation of, compositions containing, and the uses of, such derivatives. It also relates to a method for treating acute neurodegeneration disorders and chronic neurological disorders.
摘要翻译: 本发明涉及作为N-甲基-D-天冬氨酸受体的选择性拮抗剂的2,3(1H,4H) - 喹喔啉二酮衍生物。 更具体地说,本发明涉及5-三唑基-2,3(1H,4H) - 喹喔啉二酮衍生物及其制备方法,含有这些衍生物的用途和用途。 它还涉及治疗急性神经变性疾病和慢性神经障碍的方法。
-
公开(公告)号:US06281357B1
公开(公告)日:2001-08-28
申请号:US09381072
申请日:2000-03-24
申请人: David Charles Waite
发明人: David Charles Waite
IPC分类号: C07D20914
CPC分类号: C07D403/06 , C07C311/03 , C07C311/04 , C07D209/16
摘要: The invention provides a process for the production of a compound of formula I, which comprises reacting a compound of formula II with a compound of formula III, in the presence of a strong base and a palladium(0) catalyst, at an elevated temperature, in a solvent which does not adversely affect the reaction. Compounds of formula I may be further processed to compounds of formula V, which are useful in the treatment of inter alia migraine.
摘要翻译: 本发明提供了一种制备式I化合物的方法,该方法包括使式II化合物与式III化合物在强碱和钯(0)催化剂存在下,在升高的温度下反应, 在对反应没有不利影响的溶剂中。 可将式I化合物进一步加工成式V化合物,其可用于治疗特别是偏头痛。
-